Clinical Trials Sponsored by Montavit Ges.m.b.H.

Total 29 results

ProFem GmbH
Montavit Ges.m.b.H.

Active, not recruiting

A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)

Recurrent Vulvovaginal Candidiasis

Austria, Poland, Slovakia
Medical University of Graz
CBmed Ges.m.b.H.

Recruiting

Effects of Microbiome Modulation on Sleep in Working People (Sleep)

Sleep

Austria
Medical University of Graz
CBmed Ges.m.b.H.

Recruiting

Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome (LOLAbiome)

Cirrhosis

Austria
Medical University of Graz
CBmed Ges.m.b.H.

Active, not recruiting

Post COVID-19 Syndrome and the Gut-lung Axis

Covid19

Austria
Medical University of Graz
CBmed Ges.m.b.H.

Recruiting

Evidence Based Probiotic Therapy of Proton Pump Inhibitor Induced Dysbiosis (EBP)

Dysbiosis

Austria
Janssen-Cilag G.m.b.H

Completed

Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma

Multiple Myeloma

Germany
Janssen-Cilag G.m.b.H

Terminated

A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls

Schizophrenia

Germany
Janssen-Cilag G.m.b.H

Terminated

A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery Pain

Postoperative Pain

Germany
Janssen-Cilag G.m.b.H

Completed

A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (POLARIS)

Psoriasis

Germany
Janssen-Cilag G.m.b.H

Completed

Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r) (PEPDar)

Human Immunodeficiency Virus (HIV)

Germany
Janssen-Cilag G.m.b.H

Completed

A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy

Multiple Myeloma

Germany
Janssen-Cilag G.m.b.H

Terminated

An Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participants With Relapsed or Refractory Follicular Lymphoma

Lymphoma, Follicular

Germany
P.G.F. Industry Solutions GmbH
WPM - Wund Pflege Management Ges.m.b.H

Completed

A Postmarket Clinical Follow Up Study (PMCF) to Evaluate the Safety and Performance of VERIFORTE/Granudacyn® Med Wound Irrigation Solution.

Wounds

Austria
Janssen-Cilag G.m.b.H

Completed

A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma

Multiple Myeloma

Germany
Janssen-Cilag G.m.b.H

Completed

Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma

Multiple Myeloma

Germany
Janssen-Cilag G.m.b.H

Completed

Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine

Dementia | Alzheimer Disease | Dementia, Vascular
Aziende Chimiche Riunite Angelini Francesco S.p.A
Zak-Pharma Dienstleistung Ges.m.b.H.

Completed

Benzydamine in Sore Throat Pain Relief (BePaiR Study) (BePaiR)

Acute Sore Throat

Hungary, Poland, Russian Federation
University Hospital Muenster
Janssen-Cilag G.m.b.H

Completed

Ibrutinib and Standard Immuno-Chemotherapy in Younger, High-Risk Patients With Diffuse Large B-Cell Lymphoma (R-CHOEP-brut)

Diffuse Large B Cell Lymphoma

Germany
University of Cologne
Janssen-Cilag G.m.b.H

Recruiting

Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse (GMMG-DADA)

Multiple Myeloma

Germany
Medical University of Graz
Janssen-Cilag G.m.b.H

Recruiting

Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation

Kidney Transplantation | Pulmonary Hypertension | Haemodialysis

Austria
Charite University, Berlin, Germany
Janssen-Cilag G.m.b.H

Recruiting

Outcomes Associated With Suicidality in Inpatients With Symptoms of Depression (OASIS-D) (OASIS-D)

Depression | Suicidal Ideation | Suicide, Attempted | Suicidal and Self-injurious Behavior | Depression Moderate | Depression Severe

Germany
Charite University, Berlin, Germany
Janssen-Cilag G.m.b.H; Labor Berlin-Charité Vivantes G.m.b.H; Deutsches Rheuma-Forschungszentrum... and other collaborators

Not yet recruiting

An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus (DARALUP)

Systemic Lupus Erythematosus
Canadian Collaborative Research Network
GLOCK HEALTH, Science and Research, G.m.b.h.

Completed

GPur- Luminating Oral Cholesterol Kinetics Pilot Study (GLOCK-pilot)

Cholesterol Absorption

United States
Ludwig-Maximilians - University of Munich
Hoffmann-La Roche; Janssen-Cilag G.m.b.H

Active, not recruiting

Combination of PCI-32765 With Obinutuzumab in Untreated Follicular Lymphoma (Alternative)

Indolent Non-Hodgkin Lymphoma

Germany
Prof. Dr. med. Jens Reimer
Janssen-Cilag G.m.b.H

Unknown

Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients (ECHO)

Hepatitis C

Germany
University Hospital Heidelberg
Janssen-Cilag G.m.b.H; National Center for Tumor Diseases, Heidelberg

Terminated

Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late Salvage (DERANO)

Head and Neck Cancer | Anogenital Cancer

Germany
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC; Janssen-Cilag G.m.b.H; Daiichi Sankyo Europe, GmbH,...

Recruiting

AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT (CONNECT)

Advanced Solid Tumor

Germany
AIO-Studien-gGmbH
Bristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaborators

Recruiting

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients (CRISP)

Small-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage II

Germany
Universitätsklinikum Hamburg-Eppendorf
Bristol-Myers Squibb; Eli Lilly and Company; UCB Pharma; Merck Sharp & Dohme LLC; AbbVi... and other collaborators

Recruiting

PsoBest - The German Psoriasis Registry

Psoriasis | Psoriatic-arthritis

Germany

Clinical Trials Sponsored by Montavit Ges.m.b.H.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations